Total Funding
76
77
Total FundingPost-IPO Equity raised
Growth Score 76 in past quarter
-8 pts
Heat Score 77 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
64687
Ascelia Pharma is a biotechnology company that provides novel drugs.
- Carl Bjartmar: Chief Medical OfficerPast Role: Wilson Therapeutics, CMO
- Past Role: Ascelia Pharma, Vice President Clinical Development
About the Company
Ascelia Pharma is a biotechnology company. The company is focused on orphan oncology treatments.
